PT-141 is a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound acts by stimulating specific receptors within the body, leading to augmented sexual response. Research studies have revealed that PT-141 has the potential to effectively address a variety of sexual dysfunctions